tiprankstipranks
Relmada Therapeutics Inc (DE:4E2)
NASDAQ:4E2
Germany Market
4E2
Relmada Therapeutics
RESEARCH TOOLSreports

Relmada Therapeutics (4E2) Balance Sheet

0 Followers

Relmada Therapeutics Balance Sheet

Relmada Therapeutics's total assets for Q2 2026 were $219.06M, a decrease of -6.93% from the previous quarter. DE:4E2 total liabilities were $12.50M for the fiscal quarter, a -24.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 94.00M$ 45.82M$ 97.55M$ 152.91M$ 223.33M
Total Liabilities
$ 7.49M$ 10.30M$ 12.19M$ 12.47M$ 15.06M
Total Equity Gross Minority
$ 86.51M$ 35.52M$ 85.36M$ 140.44M$ 208.26M
Other Metrics
Currency in USD

Relmada Therapeutics Debt to Assets